Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems

Purpose: Recently, molecular cytogenetic techniques have identified novel copy number variants in individuals with schizophrenia. However, no large-scale prospective studies have been performed to characterize the broader spectrum of phenotypes associated with such copy number variants in individuals with unexplained physical and intellectual disabilities encountered in a diagnostic setting.Methods: We analyzed 38,779 individuals referred to our diagnostic laboratory for microarray testing for the presence of copy number variants encompassing 20 putative schizophrenia susceptibility loci. We also analyzed the indications for study for individuals with copy number variants overlapping those found in six individuals referred for schizophrenia.Results: After excluding larger gains or losses that encompassed additional genes outside the candidate loci (e.g., whole-arm gains/losses), we identified 1113 individuals with copy number variants encompassing schizophrenia susceptibility loci and 37 individuals with copy number variants overlapping those present in the six individuals referred to our laboratory for schizophrenia. Of these, 1035 had a copy number variant of one of six recurrent loci: 1q21.1, 15q11.2, 15q13.3, 16p11.2, 16p13.11, and 22q11.2. The indications for study for these 1150 individuals were diverse and included developmental delay, intellectual disability, autism spectrum, and multiple congenital anomalies.Conclusion: The results from our study, the largest genotype-first analysis of schizophrenia susceptibility loci to date, suggest that the phenotypic effects of copy number variants associated with schizophrenia are pleiotropic and imply the existence of shared biologic pathways among multiple neurodevelopmental conditions.

[1]  Richard M Myers,et al.  Population analysis of large copy number variants and hotspots of human genetic disease. , 2009, American journal of human genetics.

[2]  Deborah L. Levy,et al.  A recurrent 16p12.1 microdeletion suggests a two-hit model for severe developmental delay , 2010, Nature Genetics.

[3]  N. Craddock,et al.  Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk , 2009, Molecular Psychiatry.

[4]  Elvira Bramon,et al.  Disruption of the neurexin 1 gene is associated with schizophrenia. , 2009, Human molecular genetics.

[5]  M. Owen,et al.  High rates of schizophrenia in adults with velo-cardio-facial syndrome (VCFS) , 1999, Schizophrenia Research.

[6]  Edwin H. Cook,et al.  Copy-number variations associated with neuropsychiatric conditions , 2008, Nature.

[7]  Thomas W. Mühleisen,et al.  Large recurrent microdeletions associated with schizophrenia , 2008, Nature.

[8]  D. Blackwood,et al.  Chromosomal abnormalities and mental illness , 2003, Molecular Psychiatry.

[9]  I. Deary,et al.  DISC1 association, heterogeneity and interplay in schizophrenia and bipolar disorder , 2009, Molecular Psychiatry.

[10]  R. Tervo,et al.  Expanding the clinical phenotype of the 3q29 microdeletion syndrome and characterization of the reciprocal microduplication , 2008, Molecular Cytogenetics.

[11]  Pall I. Olason,et al.  Detection of sharing by descent, long-range phasing and haplotype imputation , 2008, Nature Genetics.

[12]  TL Sanderson,et al.  Neuroanatomy of comorbid schizophrenia and learning disability: a controlled study , 1999, The Lancet.

[13]  L. Shaffer,et al.  Identification of a previously unrecognized microdeletion syndrome of 16q11.2q12.2 , 2008, Clinical genetics.

[14]  Pall I. Olason,et al.  Common variants conferring risk of schizophrenia , 2009, Nature.

[15]  R. Shprintzen,et al.  Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[16]  P. Visscher,et al.  Rare chromosomal deletions and duplications increase risk of schizophrenia , 2008, Nature.

[17]  D. Clair,et al.  Association within a family of a balanced autosomal translocation with major mental illness , 1990, The Lancet.

[18]  Fikret Erdogan,et al.  Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. , 2007, Human molecular genetics.

[19]  T H Turner,et al.  Schizophrenia and mental handicap: an historical review, with implications for further research , 1989, Psychological Medicine.

[20]  Pall I. Olason,et al.  Copy number variations of chromosome 16p13.1 region associated with schizophrenia , 2011, Molecular Psychiatry.

[21]  S. Auvin,et al.  MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations , 2009, Journal of Medical Genetics.

[22]  M. McInnis,et al.  Psychiatric genetics: progress amid controversy , 2008, Nature Reviews Genetics.

[23]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[24]  I. Valencia,et al.  5q14.3 Deletion Manifesting as Mitochondrial Disease and Autism: Case Report , 2010, Journal of child neurology.

[25]  E M Wijsman,et al.  Meta-analysis of 32 genome-wide linkage studies of schizophrenia , 2009, Molecular Psychiatry.

[26]  E. Zackai,et al.  Autism Spectrum Disorders and Symptoms in Children with Molecularly Confirmed 22q11.2 Deletion Syndrome , 2005, Journal of autism and developmental disorders.

[27]  D. Rujescu,et al.  Penetrance for copy number variants associated with schizophrenia. , 2010, Human molecular genetics.

[28]  D J Porteous,et al.  Schizophrenia and affective disorders--cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. , 2001, American journal of human genetics.

[29]  J. Rosenfeld,et al.  Microdeletion of 6q16.1 encompassing EPHA7 in a child with mild neurological abnormalities and dysmorphic features: case report , 2009, Molecular Cytogenetics.

[30]  J A Veltman,et al.  CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy , 2008, Molecular Psychiatry.

[31]  G. Kirov,et al.  Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. , 2009, Human molecular genetics.

[32]  J. Stockman.  Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes , 2010 .

[33]  L. Shaffer,et al.  Molecular characterization of de novo secondary trisomy 13. , 1994, American journal of human genetics.

[34]  Eve C. Johnstone,et al.  Voxel-based morphometry of comorbid schizophrenia and learning disability: analyses in normalized and native spaces using parametric and nonparametric statistical methods , 2004, NeuroImage.

[35]  A. Singleton,et al.  Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia , 2008, Science.

[36]  P. Stankiewicz,et al.  Severe mental retardation, seizures, and hypotonia due to deletions of MEF2C , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[37]  M. King,et al.  Schizophrenia: a common disease caused by multiple rare alleles , 2007, British Journal of Psychiatry.

[38]  David B. Goldstein,et al.  A Genome-Wide Investigation of SNPs and CNVs in Schizophrenia , 2009, PLoS genetics.

[39]  J. Lieberman,et al.  Genomewide association for schizophrenia in the CATIE study: results of stage 1 , 2009, Molecular Psychiatry.

[40]  Jessica R. Wolff,et al.  Microduplications of 16p11.2 are Associated with Schizophrenia , 2009, Nature Genetics.

[41]  Leena Peltonen,et al.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. , 2003, American journal of human genetics.

[42]  S. Girirajan,et al.  Smith–Magenis syndrome , 2008, European Journal of Human Genetics.

[43]  Nick Craddock,et al.  Phenotypic and genetic complexity of psychosis , 2007, British Journal of Psychiatry.

[44]  Martin S. Taylor,et al.  Disruption of two novel genes by a translocation co-segregating with schizophrenia. , 2000, Human molecular genetics.

[45]  M. Owen,et al.  Velo-cardio-facial syndrome: a model for understanding the genetics and pathogenesis of schizophrenia , 2001, British Journal of Psychiatry.

[46]  Nuria Y. AbdulSabur,et al.  Autistic Spectrum Disorders in Velo-cardio Facial Syndrome (22q11.2 Deletion) , 2007, Journal of autism and developmental disorders.

[47]  Deborah A Nickerson,et al.  A method for rapid, targeted CNV genotyping identifies rare variants associated with neurocognitive disease. , 2009, Genome research.

[48]  N. Andreasen,et al.  Symptoms, signs, and diagnosis of schizophrenia , 1995, The Lancet.

[49]  C. Baker,et al.  Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. , 2010, Brain : a journal of neurology.

[50]  B. Torchia,et al.  Comparative analysis of copy number detection by whole-genome BAC and oligonucleotide array CGH , 2010, Molecular Cytogenetics.